:2C-T-13
{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477216562
| ImageFile1 = 2C-T-13.svg
| ImageSize1 = 200px
| ImageFile2 = 2C-T-13-3d-sticks.png
| ImageSize2 = 180px
| PIN = 2-
| OtherNames =
|Section1={{Chembox Identifiers
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 21106228
| InChI = 1/C13H21NO3S/c1-15-6-7-18-13-9-11(16-2)10(4-5-14)8-12(13)17-3/h8-9H,4-7,14H2,1-3H3
| InChIKey = PYJLRNOGMKMRTK-UHFFFAOYAS
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 123868
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H21NO3S/c1-15-6-7-18-13-9-11(16-2)10(4-5-14)8-12(13)17-3/h8-9H,4-7,14H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PYJLRNOGMKMRTK-UHFFFAOYSA-N
| CASNo_Ref = {{cascite|changed|??}}
| CASNo = 207740-30-5
| PubChem = 44350108
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = SK8JCS3S9B
| SMILES = COc1cc(SCCOC)c(cc1CCN)OC
}}
|Section2={{Chembox Properties
| C=13 | H=21 | N=1 | O=3 | S=1
| Appearance =
| Density =
| MeltingPt =
| BoilingPt =
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt = }}
}}
2C-T-13, also known as 4-(2-methoxyethylthio)-2,5-dimethoxyphenethylamine, is a psychedelic phenethylamine of the 2C family. It was presumably first synthesized by Alexander Shulgin and reported in his book PiHKAL.[http://www.erowid.org/library/books_online/pihkal/pihkal046.shtml PiHKAL #46 2C-T-13]
Chemistry
The drug has structural properties similar to mescaline and other drugs in the 2C-T series, with the most closely related compounds being 2C-T-7 and 2C-T-21.
General information
The dosage range of 2C-T-13 is typically 25 - 40 mg and its duration is approximately 6–8 hours according to Shulgin. 2C-T-13 produces many closed-eye visuals and geometric patterns. It also produces slight visual distortion.
Pharmacology
{{more medical citations needed|section|date=July 2019}}
The mechanism that produces 2C-T-13's hallucinogenic and entheogenic effects has not been specifically established; however, it is most likely to result from action as a 5-HT2A serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.
Dangers
The toxicity of 2C-T-13 is not well documented. 2C-T-13 is slightly less potent than 2C-T-7, but it may be expected that at higher doses it would display similar toxicity to that of other phenethylamines of the 2C-T family.
Legality
2C-T-13 is not scheduled in the United States, but possession and sales of 2C-T-13 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.
As of October 31, 2016, 2C-T-13 is a controlled substance (Schedule III) in Canada.{{cite web | url = http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php | title = Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines) | date = 4 May 2016 }}
References
{{Reflist}}
{{Psychedelics}}
{{Phenethylamines}}
{{DEFAULTSORT:2c-T-13}}